Nutrition Research
Volume 25, Issue 1 , Pages 65-77 , January 2005

Modifications of the radiosensitivity of a renal cancer cell line as a consequence of polyunsaturated fatty acid supplementation

Received 18 November 2003 ,Revised 7 September 2004 ,Accepted 10 September 2004.

References 

  1. Mejean A, Oudard S, Thiounn N. Prognostic factors of renal cell carcinoma. J. Urol. 2003;169(3):821–827
  2. Heinzer H, Huland E, Huland H. Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer. World J. Urol. 2001;19(2):111–119
  3. Makarewicz R, Zarzycka M, Kulinska G, Windorbska W. The value of postoperative radiotherapy in advanced renal cell cancer. Neoplasma. 1998;45(6):380–383
  4. Slaton JW, Inoue K, Perrotte P, El-Naggar AK, Swanson DA, Fidler IJ, et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am. J. Pathol. 2001;158(2):735–743
  5. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin. Cancer Res. 2001;7(10):3113–3119
  6. Takahashi M, Oka N, Naroda T, Nishitani MA, Kanda K, Kanayama HO, et al. Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma. Int. J. Urol. 2002;9(10):531–538
  7. Kugler A. Matrix metalloproteinases and their inhibitors. Anticancer Res. 1999;19(2C):1589–1592
  8. Kugler A, Hammerlein B, Thelen P, Kallerhoff M, Radzun HJ, Ringert HR. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma. J. Urol. 1998;160(5):1914–1918
  9. Giannelli G, Antonaci S. Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications. Histol. Histopathol. 2002;17(1):339–345
  10. Araya J, Maruyama M, Sassa K, Fujita T, Hayashi R, Matsui S, et al. Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001;280(1):L30–L38
  11. Wang JL, Sun Y, Wu S. Gamma-irradiation induces matrix metalloproteinase II expression in a p53-dependent manner. Mol. Carcinog. 2002;27(4):252–258
  12. Nirmala C, Jasti SL, Sawaya R, Kyritsis AP, Konduri SD, Ali-Osman F, et al. Effects of radiation on the levels of MMP-2, MMP-9 and TIMP-1 during morphogenic glial-endothelial cell interactions. Int. J. Cancer. 2000;88(5):766–771
  13. Robbins M, Ali K, McCaw R, Olsen J, Vartak S, Lubaroff D. Gamma–linolenic acid (GLA)–mediated cytotoxicity in human prostate cancer cells. Adv. Exp. Med. Biol. 1999;469:499–504
  14. Vartak S, George KC, Singh BB. Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipids. 1997;32(3):283–292
  15. Menendez J, Ropero S, delBarbacid MM, Montero S, Solanas M, Escrich E, et al. Synergistic interaction between vinorelbine and gamma–linolenic acid in breast cancer cells. Breast Cancer Res. Treat. 2002;72(3):203–219
  16. Tang DG, La E, Kern J, Kehrer JP. Fatty acid oxidation and signalling in apoptosis. Biol. Chem. 2002;383(3-4):425–442
  17. Suzuki I, Iigo M, Ishikawa C, Kuhara T, Asamoto M, Kunimoto T, et al. Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma–26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int. J. Cancer. 1997;73(4):607–612
  18. Reich R, Martin GR. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins. 1996;51(1):1–17
  19. McCabe AJ, Wallace J, Gilmore WS, Strain JJ, McGlynn H. The effect of eicosapentanoic acid on matrix metalloproteinase gene expression. Lipids. 1999;34:S217–S218
  20. McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, DeMeo MP, Collins A. The single cell gel electrophoresis assay (comet assay): a European review. Mutat. Res. 1993;288(1):47–63
  21. Olive PL, Banath JP, Durand RE. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the “Comet” assay. Radiat. Res. 1990;122(1):86–94
  22. McElligott AM, Baker AH, McGlynn H. Matrix metalloproteinase and tissue inhibitor of metalloproteinase regulation of the invasive potential of a metastatic renal cell line. Biochem. Soc. Trans. 1997;25(1):147S
  23. Hardman WE. Omega-3 fatty acids to augment cancer therapy. J. Nutr. 2002;132(11):3508S–3512S
  24. Das U. A radical approach to cancer. Med. Sci. Monit. 2002;8(4):RA79–RA92
  25. Nunez MI, McMillan TJ, Valenzuela MT, Ruiz de Almodovar JM, Pedraza V. Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells. Radiother. Oncol. 1996;39(2):155–165
  26. Daza P, Schubler H, McMillan TJ, Girod SC, Pfeiffer P. Radiosensitivity and double-strand break rejoining in tumorigenic and non-tumorigenic human epithelial cell lines. Int. J. Radiat. Biol. 1997;72(1):91–100
  27. McMillan TJ, Peacock JP. Molecular determinants of radiosensitivity in mammalian cells. Int. J. Radiat. Biol. 1994;65(1):49–55
  28. Knox SJ, Goris ML, Wessels BW. Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation. Radiother. Oncol. 1992;23:111–117
  29. Bertram JS. The molecular biology of cancer. Mol. Aspects Med. 2000;21(6):167–223
  30. Bian J, Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol. 1997;17:6330–6338
  31. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler. 1995;376(6):345–355
  32. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999;13(8):781–792

PII: S0271-5317(04)00194-0

doi: 10.1016/j.nutres.2004.09.006

Nutrition Research
Volume 25, Issue 1 , Pages 65-77 , January 2005

Article Tools

* Image Usage & Resolution